Enzyme inhibitor slows tumor growth
Rhombic lip implicated in origins of high-risk medulloblastoma
21 September 2022Active screen time: New children’s app promotes healthy eating, exercise
21 September 2022Enzyme inhibitor slows tumor growth
Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach for treating malignant tumors of the lymphatic system.
